Transforming growth factor β1 genotype polymorphisms determine AV fistula patency in hemodialysis patients
- 1 September 2003
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 64 (3), 1101-1107
- https://doi.org/10.1046/j.1523-1755.2003.00176.x
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Atopic dermatitis is associated with a low-producer transforming growth factor β1 cytokine genotypeJournal of Allergy and Clinical Immunology, 2001
- Venous neointimal hyperplasia in polytetrafluoroethylene dialysis graftsKidney International, 2001
- Role of Transforming Growth Factor β in Human DiseaseThe New England Journal of Medicine, 2000
- ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphismsTransplant Immunology, 1999
- TGF-β 1 DNA Polymorphisms, Protein Levels, and Blood PressureHypertension, 1999
- Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: a technical reportTransplant Immunology, 1998
- Polymorphisms of the Transforming Growth Factor-β1 Gene in Relation to Myocardial Infarction and Blood PressureHypertension, 1996
- In Vivo Effect of TGF-β1Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Transforming growth factor β1 preserves endothelial function after multiple brief coronary artery occlusions and reperfusionAmerican Heart Journal, 1994
- Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.JCI Insight, 1994